Due to their immunosuppressive functions, individuals taking TNF inhibitors are at a heightened risk of infection and at risk for a more severe course compared to healthy individuals not taking immunosuppressants, with up to 14% of individuals discontinuing TNF inhibitor treatment due to infections (Stober et al., 2018). This evidence concerns the gene TNF and infection.